VRTX Q4 2017 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$125B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$652M+42.1% YoY

Gross Profit

$568M87.1% margin

Operating Income

$126M19.3% margin

Net Income

$101M15.5% margin

EPS (Diluted)

$0.39

QoQ Revenue Growth

+12.7%

Cash Flow

Operating Cash Flow

$228M

Free Cash Flow

$185M

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$1.5B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$652M	$459M	+42.1%
Gross Profit	$568M	$398M	+42.5%
Operating Income	$126M	$40M	+217.2%
Net Income	$101M	$33M	+205.6%